References
- Alfred S, Stockham P, Partridge E. The feasibility of illicit drug monitoring in an emergency department setting: data from a 12-month pilot study. Proceedings from the Toxicology and Poisons Network Australasia (TAPNA) 2019 Scientific Meeting; Gold Coast, Australia: Toxicology Communications; 2019. p. 47–53.
- Stefani M, Roberts DM, Brett J. 4-Butanediol overdose mimicking toxic alcohol exposure. Clin Toxicol (Philadelphia, Pa). 2020;58(3):204–207.
- Schep LJ, Knudsen K, Slaughter RJ, et al. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila). 2012;50(6):458–470.
- Suner S, Szlatenyi CS, Wang RY. Pediatric gamma hydroxybutyrate intoxication. Acad Emerg Med. 1997; 4(11):1041–1045.
- Caldicott DGE, Kuhn M. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug? Ann Emerg Med. 2001; 37(1):99–102.
- Roberts DM, Smith MWH, Gopalakrishnan M, et al. Extreme gamma-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis. Ann Emerg Med. 2011;58(1):83–85.